2-Substituted-3-(4-bromo-2-carboxyphenyl)-5-methyl-4-thiazolidinones as potential anti-inflammatory agents

European Journal of Medicinal Chemistry

Volumn 34, Issue 3, 1999, Pages 265-269

  Goel, Bhawna ^a   Ram, Tilak ^a   Tyagi, Ritu ^a   Bansal, Ekta ^a   Kumar, Ashok ^a   Mukherjee, Devashish ^b   Sinha, Jagdish Narayan ^b  

^a LLRM MEDICAL COLLEGE   (India)

^b KING GEORGE'S MEDICAL UNIVERSITY   (India)

Author keywords

Acute toxicity; Anti inflammatory; Behavioural activities; Cardiovascular; Thiazolidinones; Ulcerogenic

Indexed keywords

ANTHRANILIC ACID DERIVATIVE; ANTIINFLAMMATORY AGENT; PHENYLBUTAZONE;

ACUTE TOXICITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG POTENCY; DRUG SCREENING; DRUG STRUCTURE; DRUG SYNTHESIS; FEMALE; INFLAMMATION; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; MENTAL DEFICIENCY; NONHUMAN; ORAL DRUG ADMINISTRATION; RAT; STRUCTURE ACTIVITY RELATION; ULCER;

EID: 0032758653     PISSN: 02235234     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0223-5234(99)80060-9     Document Type: Article

References (15)

1. Flower R.J., Moncada S., Vane J.R. Goodman & Gilman's The Basis of Pharmacological Therapeutics, 7th. 698:1997;Collier Mac Millan, London.
2. Singh I.P., Gurtu S., Kumar A., Sinha J.N., Bhargava K.P., Shanker K. K. Arch. Pharm. 317:1984;904-911.
3. Kumar A., Kumar A., Saxena A.K., Shanker K. Pharmazie. 43 (H-I):1988;45-46.
4. Walsh D.A., Moran H.W., Shamblee D.A., Welstead J.R.W.J., Nolan J.C., Sancilio L.F., Graff G. J. Med. Chem. 33:1990;2296-2304.
5. Kumar A., Jaju B.P., Sinha J.N. Ind. J. Pharm. Sci. 52 (6):1990;257-260.
6. Mishra S., Srivastava S.K., Srivastava S.D. Ind. J. M. 36-B (9):1997;826-830.
7. Kumar P., Nath C., Bhargava K.P., Shanker K. Ind. J. Chem. 218:1982;1128-1130.
8. Kumar A., Saxena K.K., Gurtu S., Sinha J.N., Shanker K. Ind. Drugs. 24:1986;1-5.
9. Kumar A., Gurtu S., Agrawal J.C., Sinha J.N., Shanker K. J. Ind. Chem. Soc. LX:1986;608-610.
10. Kumar A., Tyagi R., Bansal E., Verma R.S., Saxena K.K., Srivastava V.K. Ind. Drugs. 35 (5):1998;261-265.
11. Winter C.A., Fisley E.A., Nuss C.M. Proc. Soc. Exp. Biol. (New York). 544:1962;111.
12. Buttle G.A.N., Arcy P.F.D., Howard E.M., Kellette D.M. Nature (London). 176:1957;629.
13. Verma M., Sinha J.N., Gujrati V.R., Bhalla T.N., Bhargava K.P., Shanker K. Pharm. Res. Comm. 13 (10):1981;967.
14. Kumar A., Gurtu S., Sinha J.N., Bhargava K.P., Shanker K. Eur. J. Med. Chem. Chin. Ther. 20 (1):1985;95.
15. Smith C.C. J. Pharmacol. Exp. Therap. 100:1950;408.